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Background/Significance
▪ At LVHN, there were 27 phlebitis
incidences directly related to IV
amiodarone infusions in a three year
period on 3A/IPCU, PCU and CICU.
▪ Current practice at LVHN does not include
the use of an in-line filter for IV amiodarone
infusions.

PICO QUESTION
▪ In patients receiving intravenous
amiodarone, does the use of in-line filters
reduce the incidence of phlebitis?
▪ P: Patients receiving intravenous amiodarone
▪ I: Infusion through in-line filter

▪ C: Infusion through peripheral lines without an in-line filter
▪ O: Decreased incidence of phlebitis

Purpose
▪ To decrease IV phlebitis in patients
receiving IV amiodarone.

TRIGGER?
▪ Knowledge v. Problem
• Problem focused
• The trigger for this project is problem
focused. At LVHN there were 27
phlebitis incidences directly related to
IV amiodarone infusions in a three year
period on three cardiac units (3A/IPCU,
PCU and CICU).

EVIDENCE
▪

EBSCO CINAHL and OVID Medline were the search
engines primarily utilized to gain evidence for this project.

▪

Keywords utilized to obtain evidence were the following:
amiodarone, phlebitis, in-line filters, and infusion.

▪

Data was reviewed and synthesized from eight current
research articles on the topic of amiodarone infusions to
gain knowledge on the subject.

▪

Current literature recommends an in-line filter be utilized
for all peripheral IV infusions of amiodarone

EVIDENCE
▪ Risk factors of phlebitis can be related to the
infusion of certain caustic medications. The
nurse can have an impact on prevention.

▪ The incidence of phlebitis and infiltration is

tracked through the utilization of scales/data.

▪ Alternative delivery methods such as in-line filters

may decrease the incidence of phlebitis, therefore
improving quality and decreasing costs.

▪ Nurses must be aware of the impact of caustic

medications and their effects on patient safety.

EVIDENCE
▪ Studies have shown an increased incidence of
▪

▪

phlebitis in patients receiving amiodarone
peripherally.
Researchers have found that in-line filters are a
necessary component when administering
amiodarone.
A retrospective chart review was conducted at a
large military hospital on 273 patients receiving
amiodarone therapy and found that phlebitis is a
significant complication associated with
peripheral infusions at doses exceeding 2mg/ml.

Current Practice at LVHN
▪ Current practice at LVHN is to utilize
tubing without an in-line filter to infuse IV
amiodarone.

IMPLEMENTATION
1. Process Indicators and Outcomes
▪ In-line filters and phlebitis scores
2. Baseline Data
▪ Safety reports from 3A/IPCU, PCU and
CICU for the last three years (1/1/1112/31/13) were analyzed to determine
the number (N=27) of IV infiltrates that
were related to amiodarone.

IMPLEMENTATION
3. Design (EBP) Guideline(s)/Process
▪ Adding an in-line filter to the end of our
current tubing to infuse IV amiodarone.
▪ Data will be collected and analyzed to see
if the utilization of an in-line filter with IV
amiodarone infusion decreases the
incidence of phlebitis.

IMPLEMENTATION
4. Implemented EBP on Pilot Units
▪ A pilot study was initiated on March
31,2014 for CICU and 3A/IPCU to include
the use of an in-line filter for all peripheral
IV amiodarone infusions.
▪ The nurses on 3A/IPCU and CICU were inserviced on this pilot study by the 3A/IPCU
PCS. Log books were created for both
units for data collection purposes.

IMPLEMENTATION
5. Evaluation (Post data) of Process & Outcomes

▪ Data will be collected and analyzed to determine

whether the use of an in-line filter with IV amiodarone
infusions decreases the incidence of phlebitis.

6. Modifications to the Practice Guideline

▪ At this time, no practice guidelines at LVHN are being
modified as a result of this study.

IMPLEMENTATION
7. Network Implementation
▪ Our plan is to continue the pilot study on
the two units until September 30, 2014 to
potentially enroll a larger number of
patients into the study.
▪ Currently in-line filters have been utilized
on 18 patients. So far, only one infiltration
has occurred. This particular infiltrate
occurred in a patient with a pre-hospital IV.

Practice Change
▪ This study hopes to change the practice at
LVHN for IV amiodarone infusion with the
utilization of an in-line filter.
▪ This practice change will benefit the
patients by decreasing their risk of
phlebitis.

RESULTS
▪ Key Findings: Results are pending in hope
that utilization of in-line filters will
significantly decrease the incidence of
phlebitis with amiodarone infusions.
▪ Next steps: Continuing the pilot study,
collecting, and analyzing the data.

Implications for LVHN
▪ This practice change could potentially:
• Increase patient satisfaction
• Decrease length of stay
• Decrease cost of treatment

Strategic Dissemination of Results
■

PLAN for DISSEMINATION
■

Sharing pilot study results with Pharmacy Safety
Officer at LVHN.
■ Present findings to LVHN Practice Council for
network wide approval.
■ Present pilot study process to Patient Care
Specialists (PCSs) at monthly PCS meeting.
■ Create TLC course and coordinate in-services to
units that utilize IV amiodarone.
■ Add information to LVHN’s pharmacy infusion
website

Lessons Learned
▪ One on one education significantly

improved compliance.
▪ Nurses were receptive to this change in
the hope to improve patient care.
▪ A filter that costs $1.80 could
potentially save the patient from
discomfort, increased length of stay, and
increased overall cost of treatment.
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Make It Happen
▪ Questions/Comments:
Contact Information:
Julia Becker (610) 402-6860
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